Thus, perturbations in PIP3 levels affect cellular homeostasis in both normal and cancer cells, which accounts for the fact that PIK3C/PI3K inhibitors induced a wide variety of toxic effects during clinical trials in cancer therapy [83]. Here, PIK3CD is linked to cancer.